| Trends in using mesenchymal stromal/stem cells (MSCs) in treating corneal diseases J Venkatakrishnan, Y Saeed, WWY Kao The Ocular Surface 26, 255-267, 2022 | 6 | 2022 |
| Self-complementary AAV vector therapy for treating corneal cloudiness of mucopolysaccharidosis type VII (MPS VII) J Venkatakrishnan, Y Yuan, J Zhang, Y Yu, YC Hu, WWY Kao The Ocular Surface 32, 39-47, 2024 | | 2024 |
| Impaired healing in an incision wound in corneal stroma in a lumican-null mouse E Suzuki, T Sumioka, S Saika, M Miyajima, S Yasuda, H Iwanishi, ... The Ocular Surface 30, 286-294, 2023 | | 2023 |
| The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR Gene Editing F Dong, H Amlal, J Venkatakrishnan, J Zhang, M Fry, Y Yuan, YC Cheng, ... The Ocular Surface 29, 432-443, 2023 | | 2023 |
| Cell and Gene Therapy for Treating Acquired and Inherited Corneal Disorders J Venkatakrishnan University of Cincinnati, 2023 | | 2023 |
| Effect of Umbilical cord derived mesenchymal stem cells (UMSCs) in treating acquired/congenital ocular surface disorders J Venkatakrishnan, J Zhang, F Dong, K Wang, CSY Hsieh Investigative Ophthalmology & Visual Science 61 (7), 367-367, 2020 | | 2020 |
Winston Whei Yang KaoProfessor of Ophthalmology, University of CincinnatiVerified email at UC.Edu
